BackSpruce Biosciences Overview

Spruce Biosciences Other Current Liabilities

Spruce Biosciences's other current liabilities is $8.1M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$8.10M
23.31% YoYΔ $-2.46M vs prior year quarter

Peer average

Loading

Spruce Biosciences Other Current Liabilities History

Loading

Spruce Biosciences vs. peers: Other Current Liabilities Comparison

Loading

Spruce Biosciences Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Spruce Biosciences (SPRB) FAQ

As of the most recent data (March 2026), SPRB shows a other current liabilities of $8.1M. That compares with $11M in the prior-year period — down 23.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SPRB's other current liabilities is now $8.1M (was $11M) — a 23.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Spruce Biosciences is outperforming or lagging.

Tracking SPRB's other current liabilities over time shows whether Spruce Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $8.1M That compares with $11M in the prior-year period — down 23.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Spruce Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $8.1M) with ownership activity and broader fundamentals.

Spruce Biosciences's other current liabilities is $8.1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.